Deuterated tryptamine derivatives and methods of use
US12291499B2 · kind B2 · utility
0Cited by
53References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 8, 2024 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Mar 8, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.